HuagongsheHuagongshe Chemistry Print Report · For research reference only
1-(3-Methyl-1,2,4-oxadiazol-5-yl)methoxy-3,4-dinitrobenzene → 4-(6-((3-Methyl-1,2,4-oxadiazol-5-yl)methoxy)-1H-benzo[d]imidazol-2-yl)-N-(1H-indol-5-yl)benzamide
Participants
| Role | Name | HCID | Charge |
|---|---|---|---|
| Reactant | 1-(3-Methyl-1,2,4-oxadiazol-5-yl)methoxy-3,4-dinitrobenzene | HCID 86674006 | — |
| Reactant | 4-(5-Indolylaminocarbonyl)benzaldehyde | HCID 86674016 | — |
| Product | 4-(6-((3-Methyl-1,2,4-oxadiazol-5-yl)methoxy)-1H-benzo[d]imidazol-2-yl)-N-(1H-indol-5-yl)benzamide | HCID 67687363 | — |
Reaction Steps
Compound 659 was prepared according to the procedure similar to that described in Scheme III from 1-(3-methyl-1,2,4-oxadiazol-5-yl)methoxy-3,4-dinitrobenzene and 4-(5-indolylaminocarbonyl)benzaldehyde. [M+H]+ calcd for C26H20N6O3: 465.16; found: 464.98.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patent number | US09144557B2 |
| Source dataset | uspto-grants-2015_09 |
| ORD ID | ord-f314500bd63d46b3b633984af1972bf1 |
| Source note | uspto-grants-2015_09 |